| 2025-08-18 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
4,145,706 |
0 |
|
|
|
| 2025-08-14 |
13G/A
|
NGNE / Neurogene Inc.
|
|
1,486,313 |
991,804 |
|
|
|
| 2025-08-14 |
13G/A
|
IMTX / Immatics N.V.
|
|
7,275,830 |
10,168,901 |
|
|
|
| 2025-08-14 |
13G/A
|
EWTX / Edgewise Therapeutics, Inc.
|
|
5,840,059 |
7,305,940 |
|
|
|
| 2025-08-14 |
13G/A
|
CERS / Cerus Corporation
|
|
19,497,203 |
12,903,708 |
|
|
|
| 2025-08-14 |
13G
|
RVMD / Revolution Medicines, Inc.
|
|
|
9,364,972 |
|
|
|
| 2025-08-01 |
13D
|
CELC / Celcuity Inc.
|
|
4,257,735 |
7,745,692 |
|
|
|
| 2025-06-30 |
13D/A
|
KYMR / Kymera Therapeutics, Inc.
|
|
6,001,262 |
6,666,540 |
|
|
|
| 2025-06-13 |
13D/A
|
PRLD / Prelude Therapeutics Incorporated
|
|
10,222,968 |
10,269,968 |
|
|
|
| 2025-05-15 |
13G/A
|
CADL / Candel Therapeutics, Inc.
|
|
2,981,983 |
2,455,108 |
|
|
|
| 2025-05-15 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
6,398,365 |
5,604,483 |
|
|
|
| 2025-05-15 |
13G
|
NGNE / Neurogene Inc.
|
|
649,685 |
1,486,313 |
|
|
|
| 2025-04-07 |
13G/A
|
CELC / Celcuity Inc.
|
|
2,678,553 |
4,257,735 |
|
|
|
| 2025-03-31 |
13D/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
23,489,669 |
23,489,663 |
|
|
|
| 2025-03-07 |
13D
|
REPL / Replimune Group, Inc.
|
|
11,045,336 |
11,045,336 |
|
|
|
| 2025-02-14 |
13D
|
SERA / Sera Prognostics, Inc.
|
|
5,434,399 |
5,498,170 |
|
|
|
| 2025-02-14 |
13G/A
|
IMTX / Immatics N.V.
|
|
5,838,853 |
7,275,830 |
|
|
|
| 2025-02-14 |
13G
|
CADL / Candel Therapeutics, Inc.
|
|
|
2,981,983 |
|
|
|
| 2025-02-14 |
13G/A
|
CELC / Celcuity Inc.
|
|
1,874,978 |
2,678,553 |
|
|
|
| 2025-02-14 |
13G/A
|
BMEA / Biomea Fusion, Inc.
|
|
2,108,949 |
1,451,990 |
|
|
|
| 2024-12-31 |
13D/A
|
KALA / KALA BIO, Inc.
|
|
891,335 |
1,201,894 |
|
|
|
| 2024-12-17 |
13D/A
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
9,399,960 |
10,885,357 |
|
|
|
| 2024-12-10 |
13D/A
|
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
|
|
138,678,037 |
125,276,610 |
|
|
|
| 2024-11-14 |
13G
|
CELC / Celcuity Inc.
|
|
|
1,874,978 |
|
|
|
| 2024-11-14 |
13G/A
|
SGMT / Sagimet Biosciences Inc.
|
|
1,456,518 |
1,538,489 |
|
|
|
| 2024-11-14 |
13G
|
STOK / Stoke Therapeutics, Inc.
|
|
|
4,368,443 |
|
|
|
| 2024-11-14 |
13G/A
|
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
|
|
3,311,567 |
0 |
|
|
|
| 2024-11-14 |
13G/A
|
AVTE / Aerovate Therapeutics, Inc.
|
|
1,680,517 |
628,939 |
|
|
|
| 2024-11-14 |
13G/A
|
NRIX / Nurix Therapeutics, Inc.
|
|
4,952,452 |
6,751,565 |
|
|
|
| 2024-11-14 |
13G/A
|
REPL / Replimune Group, Inc.
|
|
9,545,336 |
11,045,336 |
|
|
|
| 2024-11-14 |
13G/A
|
ATHA / Athira Pharma, Inc.
|
|
3,153,807 |
0 |
|
|
|
| 2024-11-14 |
13G
|
EWTX / Edgewise Therapeutics, Inc.
|
|
|
5,840,059 |
|
|
|
| 2024-11-14 |
13G/A
|
ABCL / AbCellera Biologics Inc.
|
|
22,909,753 |
27,525,640 |
|
|
|
| 2024-10-10 |
13D/A
|
TLIS / Talis Biomedical Corporation
|
|
37,576,293 |
2,507,193 |
|
|
|
| 2024-10-08 |
13D/A
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
2,903,030 |
3,151,029 |
|
|
|
| 2024-08-22 |
13D/A
|
KYMR / Kymera Therapeutics, Inc.
|
|
5,997,706 |
6,001,262 |
|
|
|
| 2024-06-28 |
13D
|
KALA / KALA BIO, Inc.
|
|
269,213 |
891,335 |
|
|
|
| 2024-06-26 |
13D/A
|
TRDA / Entrada Therapeutics, Inc.
|
|
4,704,419 |
4,865,819 |
|
|
|
| 2024-06-14 |
13D
|
HOOK / HOOKIPA Pharma Inc.
|
|
8,148,985 |
9,813,151 |
|
|
|
| 2024-06-14 |
13D/A
|
INCY / Incyte Corporation
|
|
36,669,079 |
31,209,896 |
|
|
|
| 2024-05-28 |
13D/A
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
7,689,243 |
9,399,960 |
|
|
|
| 2024-05-13 |
13D/A
|
INCY / Incyte Corporation
|
|
36,669,079 |
36,669,079 |
|
|
|
| 2024-05-09 |
13D/A
|
INCY / Incyte Corporation
|
|
36,641,462 |
36,669,079 |
|
|
|
| 2024-04-23 |
13D/A
|
TCRX / TScan Therapeutics, Inc.
|
|
2,793,938 |
2,828,938 |
|
|
|
| 2024-04-18 |
13D
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
4,823,598 |
7,689,243 |
|
|
|
| 2024-04-01 |
13D
|
KYMR / Kymera Therapeutics, Inc.
|
|
5,995,928 |
5,997,706 |
|
|
|
| 2024-03-28 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,744,669 |
4,145,706 |
|
|
|
| 2024-03-25 |
13D/A
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
1,987,702 |
2,070,544 |
|
|
|
| 2024-03-05 |
13D
|
VTVT / vTv Therapeutics Inc.
|
|
|
122,664 |
|
|
|
| 2024-02-14 |
13G/A
|
KALA / KALA BIO, Inc.
|
|
180,913 |
269,213 |
|
|
|
| 2024-02-14 |
13G/A
|
BMEA / Biomea Fusion, Inc.
|
|
2,104,559 |
2,108,949 |
|
|
|
| 2024-02-14 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
8,131,678 |
7,881,933 |
|
|
|
| 2024-02-14 |
13G/A
|
CERS / Cerus Corporation
|
|
19,101,876 |
19,497,203 |
|
|
|
| 2024-02-14 |
13G
|
SGMT / Sagimet Biosciences Inc.
|
|
|
1,456,518 |
|
|
|
| 2024-02-14 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
19,184,794 |
10,204,089 |
|
|
|
| 2024-02-14 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
4,954,855 |
0 |
|
|
|
| 2024-02-14 |
13G/A
|
ARAV / Aravive, Inc.
|
|
4,586,404 |
3,863,568 |
|
|
|
| 2024-02-14 |
13G/A
|
NRIX / Nurix Therapeutics, Inc.
|
|
4,801,954 |
4,952,452 |
|
|
|
| 2024-02-14 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
6,354,608 |
6,398,365 |
|
|
|
| 2024-02-14 |
13G
|
ATHA / Athira Pharma, Inc.
|
|
|
3,153,807 |
|
|
|
| 2024-02-14 |
13G/A
|
SYRE / Spyre Therapeutics, Inc.
|
|
|
0 |
|
|
|
| 2024-02-14 |
13G/A
|
CABA / Cabaletta Bio, Inc.
|
|
1,344,000 |
1,457,626 |
|
|
|
| 2024-02-14 |
13G/A
|
CYTT / Cyteir Therapeutics, Inc.
|
|
2,492,118 |
0 |
|
|
|
| 2024-02-14 |
13G/A
|
AKRO / Akero Therapeutics, Inc.
|
|
2,368,378 |
2,368,378 |
|
|
|
| 2024-02-14 |
13G/A
|
ALGS / Aligos Therapeutics, Inc.
|
|
2,076,400 |
3,664,013 |
|
|
|
| 2024-02-14 |
13G/A
|
HOOK / HOOKIPA Pharma Inc.
|
|
3,475,535 |
8,148,985 |
|
|
|
| 2024-02-14 |
13G/A
|
AVTE / Aerovate Therapeutics, Inc.
|
|
1,976,868 |
1,680,517 |
|
|
|
| 2024-02-14 |
13G/A
|
OPT / Opthea Limited - Depositary Receipt (Common Stock)
|
|
31,627,844 |
28,100,345 |
|
|
|
| 2024-02-14 |
13G/A
|
IMTX / Immatics N.V.
|
|
5,187,081 |
5,838,853 |
|
|
|
| 2024-02-14 |
13G
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
4,916,095 |
|
|
|
| 2024-02-14 |
13G
|
MRTX / Mirati Therapeutics, Inc.
|
|
1,995,200 |
0 |
|
|
|
| 2024-02-14 |
13G/A
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
58,985,262 |
65,815,692 |
|
|
|
| 2024-02-14 |
13G/A
|
INZY / Inozyme Pharma, Inc.
|
|
2,168,000 |
0 |
|
|
|
| 2024-02-14 |
13G
|
ABCL / AbCellera Biologics Inc.
|
|
|
22,909,753 |
|
|
|
| 2024-02-14 |
13G/A
|
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
|
|
4,207,733 |
3,311,567 |
|
|
|
| 2024-02-14 |
13G/A
|
TSVT / 2seventy bio, Inc.
|
|
|
2,527,672 |
|
|
|
| 2024-02-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
3,814,196 |
27,000 |
|
|
|
| 2024-02-12 |
13G
|
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
4,823,598 |
|
|
|
| 2024-02-01 |
13D/A
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
4,685,690 |
2,452,871 |
|
|
|
| 2024-01-10 |
13G/A
|
KYMR / Kymera Therapeutics, Inc.
|
|
2,879,825 |
5,995,928 |
|
|
|
| 2024-01-10 |
13G
|
BCEL / Atreca, Inc.
|
|
3,532,760 |
7,677,982 |
|
|
|
| 2024-01-10 |
13G/A
|
REPL / Replimune Group, Inc.
|
|
5,768,227 |
9,545,336 |
|
|
|
| 2024-01-10 |
13G
|
SERA / Sera Prognostics, Inc.
|
|
|
5,434,399 |
|
|
|
| 2023-12-20 |
13D/A
|
NGNE / Neurogene Inc.
|
|
9,472,098 |
649,685 |
|
|
|
| 2023-12-18 |
13D/A
|
SGEN / Seagen Inc
|
|
45,074,469 |
0 |
|
|
|
| 2023-12-15 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,277,567 |
3,744,669 |
|
|
|
| 2023-12-13 |
13D/A
|
PRLD / Prelude Therapeutics Incorporated
|
|
10,219,080 |
10,222,968 |
|
|
|
| 2023-11-24 |
13D/A
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
2,197,919 |
2,365,472 |
|
|
|
| 2023-11-21 |
13D/A
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
2,015,760 |
1,987,702 |
|
|
|
| 2023-11-14 |
13D/A
|
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
|
|
152,978,037 |
138,678,037 |
|
|
|
| 2023-11-13 |
13G/A
|
CERS / Cerus Corporation
|
|
16,087,422 |
19,101,876 |
|
|
|
| 2023-10-10 |
13D/A
|
US64049K2033 / Neoleukin Therapeutics, Inc.
|
|
9,472,098 |
1,894,669 |
|
|
|
| 2023-10-05 |
13D/A
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
1,545,113 |
2,015,760 |
|
|
|
| 2023-08-17 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
10,043,077 |
9,472,098 |
|
|
|
| 2023-08-10 |
13G/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
69,359,359 |
14,604,391 |
|
|
|
| 2023-08-10 |
13G/A
|
VSTM / Verastem, Inc.
|
|
1,345,192 |
0 |
|
|
|
| 2023-08-08 |
13D/A
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
1,545,113 |
1,545,113 |
|
|
|
| 2023-07-19 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
4,229,827 |
10,043,077 |
|
|
|
| 2023-06-28 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,169,894 |
3,277,567 |
|
|
|
| 2023-06-20 |
13D
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
1,545,113 |
1,545,113 |
|
|
|
| 2023-06-12 |
13G/A
|
VSTM / Verastem, Inc.
|
|
26,988,898 |
1,345,192 |
|
|
|
| 2023-06-02 |
13D/A
|
TCRX / TScan Therapeutics, Inc.
|
|
2,784,792 |
2,793,938 |
|
|
|
| 2023-05-24 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
42,306,789 |
43,227,599 |
|
|
|
| 2023-05-24 |
13D/A
|
PRLD / Prelude Therapeutics Incorporated
|
|
10,126,417 |
10,219,080 |
|
|
|
| 2023-05-05 |
13D/A
|
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
|
|
154,315,490 |
152,978,037 |
|
|
|
| 2023-05-05 |
13D
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
2,491,244 |
2,197,919 |
|
|
|
| 2023-05-03 |
13D/A
|
SGEN / Seagen Inc
|
|
47,233,651 |
45,074,469 |
|
|
|
| 2023-03-15 |
13D/A
|
INCY / Incyte Corporation
|
|
36,634,354 |
36,641,462 |
|
|
|
| 2023-03-13 |
13D/A
|
SGEN / Seagen Inc
|
|
47,223,608 |
47,233,651 |
|
|
|
| 2023-03-10 |
13D/A
|
TLIS / Talis Biomedical Corporation
|
|
37,505,043 |
37,576,293 |
|
|
|
| 2023-02-14 |
13G
|
INZY / Inozyme Pharma, Inc.
|
|
|
2,168,000 |
|
|
|
| 2023-02-14 |
13G
|
KALA / KALA BIO, Inc.
|
|
|
180,913 |
|
|
|
| 2023-02-14 |
13G/A
|
AVTE / Aerovate Therapeutics, Inc.
|
|
1,831,789 |
1,976,868 |
|
|
|
| 2023-02-14 |
13G/A
|
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
|
|
4,039,480 |
4,207,733 |
|
|
|
| 2023-02-14 |
13G/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
64,917,601 |
69,359,359 |
|
|
|
| 2023-02-14 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
4,541,604 |
4,954,855 |
|
|
|
| 2023-02-14 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
6,062,702 |
6,354,608 |
|
|
|
| 2023-02-14 |
13G/A
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
1,499,213 |
1,545,113 |
|
|
|
| 2023-02-14 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
18,464,744 |
19,184,794 |
|
|
|
| 2023-02-14 |
13G
|
AGLE / Aeglea BioTherapeutics Inc
|
|
5,044,478 |
6,384,013 |
|
|
|
| 2023-02-14 |
13G
|
ARAV / Aravive, Inc.
|
|
1,426,310 |
4,586,404 |
|
|
|
| 2023-02-14 |
13G/A
|
NRIX / Nurix Therapeutics, Inc.
|
|
2,454,082 |
4,801,954 |
|
|
|
| 2023-02-14 |
13G
|
CYTT / Cyteir Therapeutics, Inc.
|
|
|
2,492,118 |
|
|
|
| 2023-02-14 |
13G
|
CABA / Cabaletta Bio, Inc.
|
|
|
1,344,000 |
|
|
|
| 2023-02-14 |
13G/A
|
MRUS / Merus N.V.
|
|
2,037,469 |
0 |
|
|
|
| 2023-02-14 |
13G
|
KYMR / Kymera Therapeutics, Inc.
|
|
|
2,879,825 |
|
|
|
| 2023-02-14 |
13G
|
REPL / Replimune Group, Inc.
|
|
|
5,768,227 |
|
|
|
| 2023-02-14 |
13G/A
|
IMTX / Immatics N.V.
|
|
4,423,731 |
5,187,081 |
|
|
|
| 2023-02-14 |
13G
|
BMEA / Biomea Fusion, Inc.
|
|
|
2,104,559 |
|
|
|
| 2023-02-14 |
13G
|
HOOK / HOOKIPA Pharma Inc.
|
|
|
3,475,535 |
|
|
|
| 2023-02-14 |
13G
|
TSVT / 2seventy bio, Inc.
|
|
|
2,062,744 |
|
|
|
| 2023-02-14 |
13G/A
|
CERS / Cerus Corporation
|
|
13,733,059 |
16,087,422 |
|
|
|
| 2023-02-14 |
13G/A
|
VSTM / Verastem, Inc.
|
|
21,491,630 |
26,988,898 |
|
|
|
| 2023-02-14 |
13G
|
AKRO / Akero Therapeutics, Inc.
|
|
|
2,368,378 |
|
|
|
| 2023-02-14 |
13G/A
|
OPT / Opthea Limited - Depositary Receipt (Common Stock)
|
|
26,427,521 |
31,627,844 |
|
|
|
| 2023-02-14 |
13G/A
|
SRZN / Surrozen, Inc.
|
|
3,333,333 |
833,333 |
|
|
|
| 2023-02-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
|
3,814,196 |
|
|
|
| 2023-02-10 |
13G/A
|
OTIC / Otonomy Inc
|
|
3,448,263 |
0 |
|
|
|
| 2023-01-17 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
41,167,857 |
42,306,789 |
|
|
|
| 2022-12-12 |
13G/A
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
21,293,177 |
0 |
|
|
|
| 2022-11-10 |
13G/A
|
OTIC / Otonomy Inc
|
|
7,844,692 |
3,448,263 |
|
|
|
| 2022-10-07 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
3,863,239 |
6,062,702 |
|
|
|
| 2022-07-20 |
13D/A
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
3,352,357 |
4,685,690 |
|
|
|
| 2022-06-13 |
13D/A
|
TLIS / Talis Biomedical Corporation
|
|
37,439,210 |
37,505,043 |
|
|
|
| 2022-06-13 |
13D/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
11,164,669 |
23,489,669 |
|
|
|
| 2022-06-06 |
13D/A
|
KOD / Kodiak Sciences Inc.
|
|
16,431,091 |
17,353,846 |
|
|
|
| 2022-05-18 |
13D/A
|
KOD / Kodiak Sciences Inc.
|
|
15,566,068 |
16,431,091 |
|
|
|
| 2022-05-12 |
13D/A
|
TCRX / TScan Therapeutics, Inc.
|
|
1,425,000 |
2,784,792 |
|
|
|
| 2022-04-05 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,157,784 |
3,169,894 |
|
|
|
| 2022-03-10 |
13D/A
|
INCY / Incyte Corporation
|
|
35,216,618 |
36,634,354 |
|
|
|
| 2022-03-10 |
13D/A
|
SGEN / Seagen Inc
|
|
47,618,503 |
47,223,608 |
|
|
|
| 2022-02-14 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
18,178,881 |
18,464,744 |
|
|
|
| 2022-02-14 |
13G/A
|
NVTA / Invitae Corporation
|
|
15,774,095 |
9,873,488 |
|
|
|
| 2022-02-14 |
13G
|
IMTX / Immatics N.V.
|
|
|
4,423,731 |
|
|
|
| 2022-02-14 |
13G/A
|
ALT / Altimmune, Inc.
|
|
1,884,451 |
1,941,604 |
|
|
|
| 2022-02-14 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
2,314,873 |
3,863,239 |
|
|
|
| 2022-02-14 |
13G/A
|
OPT / Opthea Limited - Depositary Receipt (Common Stock)
|
|
33,963,240 |
26,427,521 |
|
|
|
| 2022-02-14 |
13G
|
ALGS / Aligos Therapeutics, Inc.
|
|
|
2,076,400 |
|
|
|
| 2022-02-14 |
13D/A
|
INCY / Incyte Corporation
|
|
32,524,420 |
35,216,618 |
|
|
|
| 2022-02-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
4,909,810 |
4,977,296 |
|
|
|
| 2022-02-14 |
13G/A
|
OTIC / Otonomy Inc
|
|
7,220,074 |
7,844,692 |
|
|
|
| 2022-02-14 |
13G/A
|
VSTM / Verastem, Inc.
|
|
18,685,695 |
21,491,630 |
|
|
|
| 2022-02-14 |
13G/A
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
39,631,929 |
64,917,601 |
|
|
|
| 2022-02-14 |
13G
|
GBT / Global Blood Therapeutics Inc.
|
|
|
3,314,765 |
|
|
|
| 2022-02-14 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
8,064,832 |
8,131,678 |
|
|
|
| 2022-02-14 |
13G
|
AVTE / Aerovate Therapeutics, Inc.
|
|
|
1,831,789 |
|
|
|
| 2022-02-14 |
13G
|
NRIX / Nurix Therapeutics, Inc.
|
|
|
2,454,082 |
|
|
|
| 2022-02-14 |
13G
|
SRZN / Surrozen, Inc.
|
|
|
3,333,333 |
|
|
|
| 2022-02-14 |
13G
|
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
4,039,480 |
|
|
|
| 2022-02-14 |
13G/A
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
28,115,133 |
21,293,177 |
|
|
|
| 2022-02-14 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
3,540,270 |
4,541,604 |
|
|
|
| 2022-02-10 |
13D/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
4,901,190 |
5,044,478 |
|
|
|
| 2022-01-31 |
13D/A
|
KOD / Kodiak Sciences Inc.
|
|
14,717,292 |
15,566,068 |
|
|
|
| 2021-12-16 |
13D
|
TRDA / Entrada Therapeutics, Inc.
|
|
4,704,419 |
4,704,419 |
|
|
|
| 2021-11-10 |
13G
|
TRDA / Entrada Therapeutics, Inc.
|
|
|
4,704,419 |
|
|
|
| 2021-10-01 |
13D/A
|
KOD / Kodiak Sciences Inc.
|
|
14,323,868 |
14,717,292 |
|
|
|
| 2021-07-26 |
13D/A
|
KOD / Kodiak Sciences Inc.
|
|
14,054,698 |
14,323,868 |
|
|
|
| 2021-07-22 |
13D
|
TCRX / TScan Therapeutics, Inc.
|
|
|
1,425,000 |
|
|
|
| 2021-05-20 |
13D
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
3,352,357 |
3,352,357 |
|
|
|
| 2021-05-18 |
13D/A
|
INCY / Incyte Corporation
|
|
32,581,959 |
32,524,420 |
|
|
|
| 2021-05-18 |
13D/A
|
SGEN / Seagen Inc
|
|
47,615,277 |
47,618,503 |
|
|
|
| 2021-05-10 |
13G/A
|
VSTM / Verastem, Inc.
|
|
10,144,039 |
18,685,695 |
|
|
|
| 2021-04-12 |
13G
|
OTIC / Otonomy Inc
|
|
|
7,220,074 |
|
|
|
| 2021-04-09 |
13G/A
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
4,641,311 |
2,088,464 |
|
|
|
| 2021-04-02 |
13D/A
|
TLIS / Talis Biomedical Corporation
|
|
37,439,210 |
37,439,210 |
|
|
|
| 2021-03-19 |
13D/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
4,892,533 |
4,901,190 |
|
|
|
| 2021-03-05 |
13D
|
AGLE / Aeglea BioTherapeutics Inc
|
|
4,892,533 |
4,892,533 |
|
|
|
| 2021-03-05 |
13D/A
|
KOD / Kodiak Sciences Inc.
|
|
14,054,698 |
14,054,698 |
|
|
|
| 2021-02-26 |
13D
|
TLIS / Talis Biomedical Corporation
|
|
|
37,439,210 |
|
|
|
| 2021-02-16 |
13G
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
3,352,357 |
|
|
|
| 2021-02-16 |
13G/A
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
34,620,057 |
28,115,133 |
|
|
|
| 2021-02-16 |
13G/A
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
1,169,278 |
1,499,213 |
|
|
|
| 2021-02-16 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
7,979,853 |
8,064,832 |
|
|
|
| 2021-02-16 |
13G/A
|
NVTA / Invitae Corporation
|
|
9,222,078 |
15,774,095 |
|
|
|
| 2021-02-16 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
3,390,270 |
3,540,270 |
|
|
|
| 2021-02-16 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
2,708,200 |
2,314,873 |
|
|
|
| 2021-02-16 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
15,875,125 |
18,178,881 |
|
|
|
| 2021-02-16 |
13G
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
|
39,631,929 |
|
|
|
| 2021-02-16 |
13G/A
|
IFRX / InflaRx N.V.
|
|
1,778,415 |
856,228 |
|
|
|
| 2021-02-16 |
13G/A
|
CERS / Cerus Corporation
|
|
10,769,801 |
13,733,059 |
|
|
|
| 2021-02-16 |
13G/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
1,713,604 |
4,892,533 |
|
|
|
| 2021-02-16 |
13G
|
OPT / Opthea Limited - Depositary Receipt (Common Stock)
|
|
|
33,963,240 |
|
|
|
| 2021-02-16 |
13G
|
VSTM / Verastem, Inc.
|
|
|
10,144,039 |
|
|
|
| 2021-02-16 |
13G
|
ALT / Altimmune, Inc.
|
|
|
1,884,451 |
|
|
|
| 2021-02-16 |
13G/A
|
KRYS / Krystal Biotech, Inc.
|
|
1,034,674 |
698,874 |
|
|
|
| 2021-02-16 |
13G
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
58,985,262 |
|
|
|
| 2021-02-05 |
13G
|
ZYME / Zymeworks Inc.
|
|
4,909,810 |
4,909,810 |
|
|
|
| 2021-01-29 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,157,271 |
3,157,784 |
|
|
|
| 2021-01-29 |
13D/A
|
ZYME / Zymeworks Inc.
|
|
4,862,414 |
4,909,810 |
|
|
|
| 2021-01-29 |
13D/A
|
PRLD / Prelude Therapeutics Incorporated
|
|
10,121,228 |
10,126,417 |
|
|
|
| 2021-01-29 |
13G/A
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
4,696,102 |
4,641,311 |
|
|
|
| 2021-01-05 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,193,022 |
3,157,271 |
|
|
|
| 2020-12-23 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
3,805,000 |
4,229,827 |
|
|
|
| 2020-12-11 |
13D/A
|
IGMS / IGM Biosciences, Inc.
|
|
3,144,000 |
3,193,022 |
|
|
|
| 2020-12-04 |
13D/A
|
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
173,965,588 |
154,315,490 |
|
|
|
| 2020-11-24 |
13D/A
|
KOD / Kodiak Sciences Inc.
|
|
12,275,749 |
14,054,698 |
|
|
|
| 2020-09-30 |
13D
|
PRLD / Prelude Therapeutics Incorporated
|
|
|
10,121,228 |
|
|
|
| 2020-09-08 |
13D/A
|
KOD / Kodiak Sciences Inc.
|
|
11,574,537 |
12,275,749 |
|
|
|
| 2020-07-28 |
13D/A
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
2,896,777 |
2,903,030 |
|
|
|
| 2020-07-17 |
13D/A
|
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
159,118,860 |
173,965,588 |
|
|
|
| 2020-05-19 |
13D/A
|
SGEN / Seagen Inc
|
|
49,365,277 |
47,615,277 |
|
|
|
| 2020-05-18 |
13D/A
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
2,896,777 |
|
|
|
| 2020-05-08 |
13D/A
|
SGEN / Seagen Inc
|
|
50,423,593 |
49,365,277 |
|
|
|
| 2020-04-29 |
13D/A
|
INCY / Incyte Corporation
|
|
32,551,585 |
32,581,959 |
|
|
|
| 2020-04-24 |
13D/A
|
SGEN / Seagen Inc
|
|
51,305,232 |
50,423,593 |
|
|
|
| 2020-03-25 |
13D
|
ZYME / Zymeworks Inc.
|
|
4,181,872 |
4,862,414 |
|
|
|
| 2020-02-26 |
13D/A
|
KOD / Kodiak Sciences Inc.
|
|
11,197,288 |
11,574,537 |
|
|
|
| 2020-02-14 |
13G/A
|
CBAY / CymaBay Therapeutics, Inc.
|
|
4,917,700 |
0 |
|
|
|
| 2020-02-14 |
13G/A
|
MDGN / Medgenics, Inc.
|
|
3,950,419 |
564,844 |
|
|
|
| 2020-02-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
1,708,472 |
4,181,872 |
|
|
|
| 2020-02-14 |
13G/A
|
CFRX / ContraFect Corp
|
|
8,019,576 |
5,553,599 |
|
|
|
| 2020-02-14 |
13G/A
|
NVTA / Invitae Corporation
|
|
4,885,553 |
9,222,078 |
|
|
|
| 2020-02-14 |
13G/A
|
US74257L1089 / Principia Biopharma Inc.
|
|
1,808,745 |
1,808,684 |
|
|
|
| 2020-02-14 |
13G
|
BCEL / Atreca, Inc.
|
|
|
3,532,760 |
|
|
|
| 2020-02-14 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
2,837,352 |
3,390,270 |
|
|
|
| 2020-02-14 |
13G/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
1,713,604 |
1,713,604 |
|
|
|
| 2020-02-14 |
13G/A
|
MRUS / Merus N.V.
|
|
1,160,014 |
2,037,469 |
|
|
|
| 2020-02-14 |
13G
|
IFRX / InflaRx N.V.
|
|
|
1,778,415 |
|
|
|
| 2020-02-14 |
13G/A
|
KRYS / Krystal Biotech, Inc.
|
|
784,674 |
1,034,674 |
|
|
|
| 2020-02-14 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
6,908,244 |
7,979,853 |
|
|
|
| 2020-02-14 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
15,171,540 |
15,875,125 |
|
|
|
| 2020-02-14 |
13G/A
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
42,592,824 |
34,620,057 |
|
|
|
| 2020-01-24 |
13D/A
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
2,677,818 |
2,491,244 |
|
|
|
| 2020-01-07 |
13D/A
|
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
159,118,860 |
159,118,860 |
|
|
|
| 2019-12-20 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
11,307,939 |
3,805,000 |
|
|
|
| 2019-12-06 |
13D/A
|
KOD / Kodiak Sciences Inc.
|
|
9,295,115 |
11,197,288 |
|
|
|
| 2019-11-18 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
11,361,939 |
11,307,939 |
|
|
|
| 2019-11-06 |
13D/A
|
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
155,703,388 |
159,118,860 |
|
|
|
| 2019-10-11 |
13D/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
6,612,318 |
11,164,669 |
|
|
|
| 2019-10-04 |
13D/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
3,588,848 |
1,995,200 |
|
|
|
| 2019-09-20 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
39,924,489 |
41,167,857 |
|
|
|
| 2019-09-20 |
13D
|
IGMS / IGM Biosciences, Inc.
|
|
|
3,144,000 |
|
|
|
| 2019-09-06 |
13G
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
4,898,847 |
4,696,102 |
|
|
|
| 2019-08-22 |
13D
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
2,677,818 |
2,677,818 |
|
|
|
| 2019-08-13 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
11,361,939 |
|
|
|
| 2019-08-07 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
10,936,414 |
11,361,939 |
|
|
|
| 2019-07-31 |
13D/A
|
GHDX / Genomic Health, Inc.
|
|
9,595,599 |
9,596,023 |
|
|
|
| 2019-07-30 |
13D/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
2,712,984 |
3,588,848 |
|
|
|
| 2019-06-07 |
13D/A
|
INCY / Incyte Corporation
|
|
34,521,176 |
32,551,585 |
|
|
|
| 2019-06-07 |
13D/A
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
3,031,268 |
2,865,509 |
|
|
|
| 2019-06-06 |
13D/A
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
4,887,959 |
4,898,847 |
|
|
|
| 2019-05-01 |
13D/A
|
SGEN / Seagen Inc
|
|
50,831,621 |
51,305,232 |
|
|
|
| 2019-04-12 |
13D/A
|
GHDX / Genomic Health, Inc.
|
|
10,513,620 |
9,595,599 |
|
|
|
| 2019-04-09 |
13D/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
4,760,466 |
6,612,318 |
|
|
|
| 2019-03-25 |
13D/A
|
GHDX / Genomic Health, Inc.
|
|
10,890,377 |
10,513,620 |
|
|
|
| 2019-03-14 |
13D/A
|
GHDX / Genomic Health, Inc.
|
|
11,301,026 |
10,890,377 |
|
|
|
| 2019-02-28 |
13D/A
|
GHDX / Genomic Health, Inc.
|
|
11,604,693 |
11,301,026 |
|
|
|
| 2019-02-27 |
13D/A
|
INCY / Incyte Corporation
|
|
34,520,320 |
34,521,176 |
|
|
|
| 2019-02-13 |
13G/A
|
CBAY / CymaBay Therapeutics, Inc.
|
|
2,991,775 |
4,917,700 |
|
|
|
| 2019-02-13 |
13G/A
|
MDGN / Medgenics, Inc.
|
|
4,055,142 |
3,950,419 |
|
|
|
| 2019-02-13 |
13G/A
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
2,466,702 |
498,189 |
|
|
|
| 2019-02-13 |
13G/A
|
AGLE / Aeglea BioTherapeutics Inc
|
|
1,137,872 |
1,713,604 |
|
|
|
| 2019-02-13 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
14,080,631 |
15,171,540 |
|
|
|
| 2019-02-13 |
13G/A
|
CERS / Cerus Corporation
|
|
9,765,073 |
10,769,801 |
|
|
|
| 2019-02-13 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
4,852,807 |
6,908,244 |
|
|
|
| 2019-02-13 |
13G
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
1,169,278 |
|
|
|
| 2019-02-13 |
13G/A
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
40,020,809 |
42,592,824 |
|
|
|
| 2019-02-13 |
13G/A
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
4,151,578 |
2,677,818 |
|
|
|
| 2019-02-13 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
5,852,153 |
2,900,000 |
|
|
|
| 2019-02-13 |
13G
|
ZYME / Zymeworks Inc.
|
|
|
1,708,472 |
|
|
|
| 2019-02-13 |
13G/A
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
699,500 |
0 |
|
|
|
| 2019-02-13 |
13G/A
|
RTTR / Ritter Pharmaceuticals, Inc.
|
|
2,800,000 |
286,499 |
|
|
|
| 2019-02-13 |
13G/A
|
CFRX / ContraFect Corp
|
|
7,381,006 |
8,019,576 |
|
|
|
| 2019-02-13 |
13G
|
US74257L1089 / Principia Biopharma Inc.
|
|
|
1,808,745 |
|
|
|
| 2019-02-13 |
13G/A
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
2,618,818 |
2,837,352 |
|
|
|
| 2019-02-13 |
13G
|
CMTA / Clementia Pharmaceuticals Inc.
|
|
|
3,724,445 |
|
|
|
| 2019-02-13 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
2,049,020 |
2,708,200 |
|
|
|
| 2019-02-13 |
13G
|
KRYS / Krystal Biotech, Inc.
|
|
|
784,674 |
|
|
|
| 2019-02-11 |
13G/A
|
NVTA / Invitae Corporation
|
|
8,399,411 |
4,885,553 |
|
|
|
| 2019-02-06 |
13D/A
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
3,006,252 |
3,031,268 |
|
|
|
| 2019-01-22 |
13D/A
|
GHDX / Genomic Health, Inc.
|
|
12,380,267 |
11,604,693 |
|
|
|
| 2018-12-04 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
28,570,614 |
39,924,489 |
|
|
|
| 2018-12-03 |
13D/A
|
GHDX / Genomic Health, Inc.
|
|
12,838,436 |
12,380,267 |
|
|
|
| 2018-11-28 |
13D/A
|
GHDX / Genomic Health, Inc.
|
|
13,354,508 |
12,838,436 |
|
|
|
| 2018-11-13 |
13D/A
|
GHDX / Genomic Health, Inc.
|
|
14,092,863 |
13,354,508 |
|
|
|
| 2018-11-08 |
13D/A
|
EYRYY / Erytech Pharma
|
|
3,085,969 |
0 |
|
|
|
| 2018-10-12 |
13D
|
KOD / Kodiak Sciences Inc.
|
|
9,295,115 |
9,295,115 |
|
|
|
| 2018-10-11 |
13D
|
KOD / Kodiak Sciences Inc.
|
|
|
9,295,115 |
|
|
|
| 2018-10-10 |
13G/A
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
22,669,509 |
40,020,809 |
|
|
|
| 2018-09-24 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
27,339,279 |
28,570,614 |
|
|
|
| 2018-09-20 |
13D/A
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
38,956,461 |
4,887,959 |
|
|
|
| 2018-08-01 |
13D/A
|
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
155,484,836 |
155,703,388 |
|
|
|
| 2018-07-02 |
13D/A
|
EYRYY / Erytech Pharma
|
|
4,898,337 |
3,085,969 |
|
|
|
| 2018-06-26 |
13D/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
4,753,466 |
4,760,466 |
|
|
|
| 2018-05-31 |
13D
|
KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
3,006,252 |
|
|
|
| 2018-05-10 |
13G/A
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
5,032,313 |
4,151,578 |
|
|
|
| 2018-05-03 |
13D/A
|
INCY / Incyte Corporation
|
|
34,404,580 |
34,520,320 |
|
|
|
| 2018-05-02 |
13D/A
|
SGEN / Seagen Inc
|
|
49,818,661 |
50,831,621 |
|
|
|
| 2018-04-10 |
13G
|
NVTA / Invitae Corporation
|
|
7,288,300 |
8,399,411 |
|
|
|
| 2018-03-23 |
13D/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
3,638,589 |
4,753,466 |
|
|
|
| 2018-03-12 |
13D/A
|
GHDX / Genomic Health, Inc.
|
|
14,091,043 |
14,092,863 |
|
|
|
| 2018-03-06 |
13D/A
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
18,619,136 |
38,956,461 |
|
|
|
| 2018-02-13 |
13G/A
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
2,336,359 |
0 |
|
|
|
| 2018-02-13 |
13G
|
TNXP / Tonix Pharmaceuticals Holding Corp.
|
|
|
699,500 |
|
|
|
| 2018-02-13 |
13G
|
AGLE / Aeglea BioTherapeutics Inc
|
|
|
1,137,872 |
|
|
|
| 2018-02-13 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
11,062,403 |
14,080,631 |
|
|
|
| 2018-02-13 |
13G
|
CBAY / CymaBay Therapeutics, Inc.
|
|
|
2,991,775 |
|
|
|
| 2018-02-13 |
13G
|
MDGN / Medgenics, Inc.
|
|
|
4,055,142 |
|
|
|
| 2018-02-13 |
13G
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
2,049,020 |
|
|
|
| 2018-02-13 |
13G/A
|
ARAV / Aravive, Inc.
|
|
1,920,845 |
1,426,310 |
|
|
|
| 2018-02-13 |
13G/A
|
TRIL / Trillium Therapeutics Inc
|
|
413,697 |
668,313 |
|
|
|
| 2018-02-13 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
4,084,803 |
4,852,807 |
|
|
|
| 2018-02-13 |
13G
|
ABYLY / Ablynx NV
|
|
|
4,631,286 |
|
|
|
| 2018-02-13 |
13G
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
2,618,818 |
|
|
|
| 2018-02-13 |
13G
|
QLGN / Qualigen Therapeutics, Inc.
|
|
|
2,800,000 |
|
|
|
| 2018-02-13 |
13G/A
|
CFRX / ContraFect Corp
|
|
4,167,876 |
7,381,006 |
|
|
|
| 2018-02-13 |
13G/A
|
ACOR / Acorda Therapeutics, Inc.
|
|
3,301,791 |
205,966 |
|
|
|
| 2018-02-13 |
13G/A
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
22,169,509 |
22,669,509 |
|
|
|
| 2018-02-13 |
13G/A
|
CERS / Cerus Corporation
|
|
13,073,139 |
9,765,073 |
|
|
|
| 2018-02-13 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
5,102,153 |
5,852,153 |
|
|
|
| 2018-02-13 |
13G/A
|
ADHD / Alcobra Ltd.
|
|
|
0 |
|
|
|
| 2018-02-13 |
13G/A
|
SGMO / Sangamo Therapeutics, Inc.
|
|
4,055,876 |
2,113,376 |
|
|
|
| 2018-02-05 |
13D/A
|
SGEN / Seagen Inc
|
|
45,972,508 |
49,818,661 |
|
|
|
| 2018-01-22 |
13D/A
|
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
130,374,760 |
155,484,836 |
|
|
|
| 2018-01-10 |
13G/A
|
/ Achaogen Inc
|
|
4,582,382 |
122,482 |
|
|
|
| 2017-11-20 |
13D/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
2,549,598 |
2,712,984 |
|
|
|
| 2017-11-16 |
13D
|
EYRYY / Erytech Pharma
|
|
|
4,898,337 |
|
|
|
| 2017-10-30 |
13D/A
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
10,487,314 |
18,619,136 |
|
|
|
| 2017-10-16 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
27,372,236 |
27,339,279 |
|
|
|
| 2017-08-14 |
13D/A
|
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
128,086,032 |
130,374,760 |
|
|
|
| 2017-08-02 |
13D/A
|
NVTA / Invitae Corporation
|
|
7,288,300 |
7,288,300 |
|
|
|
| 2017-06-01 |
13D/A
|
GHDX / Genomic Health, Inc.
|
|
|
14,091,043 |
|
|
|
| 2017-05-17 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
25,878,893 |
27,372,236 |
|
|
|
| 2017-05-17 |
13D/A
|
SGEN / Seagen Inc
|
|
45,959,548 |
45,972,508 |
|
|
|
| 2017-04-28 |
13D/A
|
INCY / Incyte Corporation
|
|
|
34,404,580 |
|
|
|
| 2017-04-11 |
13G
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
5,032,313 |
5,032,313 |
|
|
|
| 2017-03-28 |
13D/A
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
4,865,647 |
5,032,313 |
|
|
|
| 2017-03-27 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
10,936,414 |
10,936,414 |
|
|
|
| 2017-03-10 |
13G/A
|
DSCI / Derma Sciences, Inc.
|
|
3,760,290 |
0 |
|
|
|
| 2017-02-14 |
13G
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
22,169,509 |
|
|
|
| 2017-02-14 |
13G/A
|
ARAV / Aravive, Inc.
|
|
2,006,227 |
1,920,845 |
|
|
|
| 2017-02-14 |
13G/A
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
3,680,499 |
0 |
|
|
|
| 2017-02-14 |
13G
|
CFRX / ContraFect Corp
|
|
|
4,167,876 |
|
|
|
| 2017-02-14 |
13G
|
MRUS / Merus N.V.
|
|
|
1,160,014 |
|
|
|
| 2017-02-14 |
13G/A
|
IMGN / ImmunoGen, Inc.
|
|
4,452,445 |
3,015,353 |
|
|
|
| 2017-02-14 |
13G/A
|
CERS / Cerus Corporation
|
|
13,573,139 |
13,073,139 |
|
|
|
| 2017-02-14 |
13G/A
|
LIFE / aTyr Pharma, Inc.
|
|
2,335,125 |
0 |
|
|
|
| 2017-02-14 |
13G/A
|
CLVS / Clovis Oncology Inc
|
|
2,089,695 |
0 |
|
|
|
| 2017-02-14 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
3,673,284 |
4,084,803 |
|
|
|
| 2017-02-14 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
4,450,000 |
741,665 |
|
|
|
| 2017-02-14 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
4,350,808 |
3,150,808 |
|
|
|
| 2017-02-14 |
13G/A
|
ACOR / Acorda Therapeutics, Inc.
|
|
3,580,112 |
3,301,791 |
|
|
|
| 2017-02-14 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
8,275,630 |
5,102,153 |
|
|
|
| 2017-02-14 |
13G/A
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
2,046,967 |
2,466,702 |
|
|
|
| 2017-01-30 |
13D/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
3,631,589 |
3,638,589 |
|
|
|
| 2017-01-10 |
13G
|
/ Achaogen Inc
|
|
|
4,582,382 |
|
|
|
| 2017-01-09 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
10,538,352 |
10,936,414 |
|
|
|
| 2016-12-09 |
13G/A
|
ARAV / Aravive, Inc.
|
|
3,241,783 |
2,006,227 |
|
|
|
| 2016-11-21 |
13D/A
|
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
105,199,597 |
128,086,032 |
|
|
|
| 2016-11-18 |
13D/A
|
NVTA / Invitae Corporation
|
|
6,554,967 |
7,288,300 |
|
|
|
| 2016-11-09 |
13D/A
|
SGEN / Seagen Inc
|
|
44,347,986 |
45,959,548 |
|
|
|
| 2016-10-11 |
13D
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
7,117,277 |
10,487,314 |
|
|
|
| 2016-09-21 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
7,754,747 |
10,538,352 |
|
|
|
| 2016-09-15 |
13D/A
|
SGEN / Seagen Inc
|
|
43,486,659 |
44,347,986 |
|
|
|
| 2016-08-17 |
13G
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
11,062,403 |
11,062,403 |
|
|
|
| 2016-08-16 |
13D/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
15,078,993 |
11,062,403 |
|
|
|
| 2016-08-12 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
24,566,113 |
25,878,893 |
|
|
|
| 2016-08-04 |
13G/A
|
XNPT / XenoPort, Inc.
|
|
6,625,672 |
0 |
|
|
|
| 2016-07-11 |
13G/A
|
032420101 / Anacor Pharmaceuticals, Inc.
|
|
4,871,046 |
0 |
|
|
|
| 2016-06-09 |
13D/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
3,548,956 |
2,549,598 |
|
|
|
| 2016-04-01 |
13D/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
3,548,956 |
|
|
|
| 2016-04-01 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
23,113,898 |
24,566,113 |
|
|
|
| 2016-03-21 |
13D/A
|
SGEN / Seagen Inc
|
|
43,353,334 |
43,486,659 |
|
|
|
| 2016-03-16 |
13D/A
|
SGEN / Seagen Inc
|
|
41,305,731 |
43,353,334 |
|
|
|
| 2016-03-16 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
7,142,294 |
7,754,747 |
|
|
|
| 2016-03-08 |
13D/A
|
SGEN / Seagen Inc
|
|
39,812,778 |
41,305,731 |
|
|
|
| 2016-02-22 |
13D/A
|
SGEN / Seagen Inc
|
|
38,811,307 |
39,812,778 |
|
|
|
| 2016-02-17 |
13D/A
|
SGEN / Seagen Inc
|
|
37,542,160 |
38,811,307 |
|
|
|
| 2016-02-16 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
871,500 |
|
|
|
| 2016-02-16 |
13G/A
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
3,680,499 |
|
|
|
| 2016-02-16 |
13G/A
|
CLVS / Clovis Oncology Inc
|
|
|
2,089,695 |
|
|
|
| 2016-02-16 |
13G/A
|
ARAV / Aravive, Inc.
|
|
|
3,241,783 |
|
|
|
| 2016-02-16 |
13G
|
ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
2,336,359 |
|
|
|
| 2016-02-16 |
13G
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
2,046,967 |
|
|
|
| 2016-02-16 |
13D/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
3,600,318 |
3,631,589 |
|
|
|
| 2016-02-16 |
13G
|
TRIL / Trillium Therapeutics Inc
|
|
|
413,697 |
|
|
|
| 2016-02-16 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
|
3,673,284 |
|
|
|
| 2016-02-16 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
4,350,808 |
|
|
|
| 2016-02-16 |
13G
|
IMGN / ImmunoGen, Inc.
|
|
|
4,452,445 |
|
|
|
| 2016-02-16 |
13G
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
|
7,117,277 |
|
|
|
| 2016-02-16 |
13G/A
|
DSCI / Derma Sciences, Inc.
|
|
|
3,760,290 |
|
|
|
| 2016-02-16 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
795,191 |
|
|
|
| 2016-02-16 |
13G/A
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
8,275,630 |
|
|
|
| 2016-02-16 |
13G
|
LIFE / aTyr Pharma, Inc.
|
|
|
2,335,125 |
|
|
|
| 2016-02-16 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
871,500 |
|
|
|
| 2016-02-16 |
13G/A
|
XNPT / XenoPort, Inc.
|
|
|
6,625,672 |
|
|
|
| 2016-02-16 |
13G/A
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
4,450,000 |
|
|
|
| 2016-02-16 |
13G/A
|
CERS / Cerus Corporation
|
|
|
13,573,139 |
|
|
|
| 2016-02-16 |
13G
|
ACOR / Acorda Therapeutics, Inc.
|
|
|
3,580,112 |
|
|
|
| 2016-02-16 |
13G
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
4,055,876 |
|
|
|
| 2016-02-10 |
13G/A
|
032420101 / Anacor Pharmaceuticals, Inc.
|
|
|
4,871,046 |
|
|
|
| 2016-02-09 |
13D
|
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
|
105,199,597 |
|
|
|
| 2016-02-04 |
13D/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
14,331,238 |
15,078,993 |
|
|
|
| 2016-01-20 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
6,952,215 |
7,142,294 |
|
|
|
| 2016-01-19 |
13D/A
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
4,865,647 |
4,865,647 |
|
|
|
| 2016-01-15 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
6,749,592 |
6,952,215 |
|
|
|
| 2016-01-08 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
23,113,898 |
|
|
|
| 2015-12-24 |
13D
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
4,865,647 |
|
|
|
| 2015-12-10 |
13G/A
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
0 |
|
|
|
| 2015-11-20 |
13D/A
|
SGEN / Seagen Inc
|
|
36,278,178 |
37,542,160 |
|
|
|
| 2015-11-06 |
13D
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
14,331,238 |
|
|
|
| 2015-09-15 |
13D
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
3,600,318 |
3,600,318 |
|
|
|
| 2015-09-15 |
13D/A
|
SGEN / Seagen Inc
|
|
30,167,808 |
36,278,178 |
|
|
|
| 2015-09-11 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
4,269,560 |
6,749,592 |
|
|
|
| 2015-08-27 |
13D
|
NVTA / Invitae Corporation
|
|
|
6,554,967 |
|
|
|
| 2015-08-11 |
13D/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
4,267,300 |
4,269,560 |
|
|
|
| 2015-08-10 |
13D
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
4,267,300 |
|
|
|
| 2015-08-10 |
13G/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
3,600,318 |
|
|
|
| 2015-06-24 |
13D/A
|
GEVA / Synageva Biopharma Corp
|
|
11,910,664 |
0 |
|
|
|
| 2015-05-08 |
13D/A
|
SGEN / Seagen Inc
|
|
|
30,167,808 |
|
|
|
| 2015-05-07 |
13D/A
|
GEVA / Synageva Biopharma Corp
|
|
|
11,910,664 |
|
|
|
| 2015-04-10 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
1,750,230 |
|
|
|
| 2015-03-10 |
13G/A
|
CLTX / Celsus Therapeutics
|
|
|
0 |
|
|
|
| 2015-02-17 |
13G/A
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
1,210,350 |
|
|
|
| 2015-02-17 |
13G/A
|
TGTX / TG Therapeutics, Inc.
|
|
|
2,050,313 |
|
|
|
| 2015-02-17 |
13G/A
|
ASMB / Assembly Biosciences, Inc.
|
|
|
0 |
|
|
|
| 2015-02-17 |
13G/A
|
032420101 / Anacor Pharmaceuticals, Inc.
|
|
|
4,204,702 |
|
|
|
| 2015-02-17 |
13G/A
|
XNPT / XenoPort, Inc.
|
|
|
6,903,628 |
|
|
|
| 2015-02-17 |
13G/A
|
HALO / Halozyme Therapeutics, Inc.
|
|
|
2,776,143 |
|
|
|
| 2015-02-17 |
13G/A
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
4,020,562 |
|
|
|
| 2015-02-17 |
13G/A
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
2,000,000 |
|
|
|
| 2015-02-17 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
1,220,423 |
|
|
|
| 2015-02-17 |
13G/A
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
4,449,797 |
|
|
|
| 2015-02-17 |
13G
|
CLVS / Clovis Oncology Inc
|
|
|
2,292,325 |
|
|
|
| 2015-02-17 |
13G/A
|
CLTX / Celsus Therapeutics
|
|
|
6,738,870 |
|
|
|
| 2015-02-17 |
13G
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
3,200,000 |
|
|
|
| 2015-02-17 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
4,472,153 |
|
|
|
| 2015-02-17 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
|
2,952,164 |
|
|
|
| 2015-02-17 |
13G
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
1,885,780 |
|
|
|
| 2015-02-17 |
13G
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
6,715,462 |
|
|
|
| 2015-02-17 |
13G/A
|
STML / Stemline Therapeutics, Inc.
|
|
|
338,671 |
|
|
|
| 2015-02-12 |
13G
|
NVTA / Invitae Corporation
|
|
|
6,554,967 |
|
|
|
| 2015-02-10 |
13G
|
ARAV / Aravive, Inc.
|
|
|
2,977,396 |
|
|
|
| 2015-02-03 |
13D/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
3,309,830 |
|
|
|
| 2015-01-12 |
13G
|
BLCM / Bellicum Pharmaceuticals, Inc.
|
|
|
4,283,732 |
|
|
|
| 2014-12-17 |
13D/A
|
SGEN / Seagen Inc
|
|
|
28,107,902 |
|
|
|
| 2014-12-11 |
13G/A
|
CERS / Cerus Corporation
|
|
|
11,722,591 |
|
|
|
| 2014-12-11 |
13D/A
|
SGEN / Seagen Inc
|
|
|
25,224,524 |
|
|
|
| 2014-11-12 |
13D/A
|
SGEN / Seagen Inc
|
|
|
24,332,651 |
|
|
|
| 2014-11-10 |
13G/A
|
AVNR / Avanir Pharmaceuticals Inc
|
|
|
32,767,078 |
|
|
|
| 2014-10-10 |
13G
|
XNPT / XenoPort, Inc.
|
|
|
6,815,777 |
|
|
|
| 2014-06-12 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
20,501,442 |
|
|
|
| 2014-06-10 |
13G
|
AVNR / Avanir Pharmaceuticals Inc
|
|
|
18,558,487 |
|
|
|
| 2014-05-16 |
13D/A
|
SGEN / Seagen Inc
|
|
|
21,633,916 |
|
|
|
| 2014-05-12 |
13D/A
|
SGEN / Seagen Inc
|
|
|
21,444,305 |
|
|
|
| 2014-04-10 |
13G
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
1,211,851 |
|
|
|
| 2014-03-07 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
20,481,442 |
|
|
|
| 2014-02-14 |
13G
|
HALO / Halozyme Therapeutics, Inc.
|
|
|
6,297,026 |
|
|
|
| 2014-02-14 |
13G
|
TGTX / TG Therapeutics, Inc.
|
|
|
2,199,656 |
|
|
|
| 2014-02-14 |
13G
|
STML / Stemline Therapeutics, Inc.
|
|
|
675,042 |
|
|
|
| 2014-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
2,336,500 |
|
|
|
| 2014-02-14 |
13G
|
CHTP / Chelsea Therapeutics International, Ltd.
|
|
|
5,794,753 |
|
|
|
| 2014-02-14 |
13G
|
032420101 / Anacor Pharmaceuticals, Inc.
|
|
|
2,500,000 |
|
|
|
| 2014-02-14 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
|
2,177,840 |
|
|
|
| 2014-02-14 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
|
46,355,851 |
|
|
|
| 2014-02-14 |
13G
|
PGNX / Progenics Pharmaceuticals, Inc.
|
|
|
4,200,000 |
|
|
|
| 2014-02-14 |
13G
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
3,954,000 |
|
|
|
| 2014-02-14 |
13G
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
22,558,069 |
|
|
|
| 2014-01-06 |
13G
|
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
5,263,162 |
|
|
|
| 2013-12-30 |
13D/A
|
MEIP / MEI Pharma, Inc.
|
|
|
746,521 |
|
|
|
| 2013-12-17 |
13D/A
|
SGEN / Seagen Inc
|
|
|
20,943,673 |
|
|
|
| 2013-10-31 |
13D/A
|
MEIP / MEI Pharma, Inc.
|
|
|
1,130,317 |
|
|
|
| 2013-10-31 |
13D
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
2,705,074 |
|
|
|
| 2013-08-12 |
13G/A
|
CERS / Cerus Corporation
|
|
|
8,455,306 |
|
|
|
| 2013-08-12 |
13G/A
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
3,966,179 |
|
|
|
| 2013-08-12 |
13G/A
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
2,778,654 |
|
|
|
| 2013-07-11 |
13D/A
|
MEIP / MEI Pharma, Inc.
|
|
|
1,215,612 |
|
|
|
| 2013-07-11 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
19,955,126 |
|
|
|
| 2013-06-10 |
13G
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
3,966,179 |
|
|
|
| 2013-06-06 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
19,955,126 |
|
|
|
| 2013-05-17 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
17,614,812 |
|
|
|
| 2013-05-10 |
13G
|
CERS / Cerus Corporation
|
|
|
8,455,306 |
|
|
|
| 2013-03-11 |
13G/A
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
2,261,154 |
|
|
|
| 2013-03-05 |
13D/A
|
MEIP / MEI Pharma, Inc.
|
|
|
1,200,000 |
|
|
|
| 2013-02-27 |
13D/A
|
MEIP / MEI Pharma, Inc.
|
|
|
1,427,017 |
|
|
|
| 2013-02-11 |
13D/A
|
GHDX / Genomic Health, Inc.
|
|
|
12,699,584 |
|
|
|
| 2013-02-11 |
13G/A
|
OCRX / Ocera Therapeutics, Inc.
|
|
|
0 |
|
|
|
| 2013-02-05 |
13G/A
|
YMI / Ym Biosciences Inc
|
|
|
0 |
|
|
|
| 2013-02-04 |
13G/A
|
AUXL / Auxilium Pharmaceuticals Inc
|
|
|
4,371,129 |
|
|
|
| 2013-02-01 |
13G/A
|
BDSI / Biodelivery Sciences International
|
|
|
3,164,426 |
|
|
|
| 2013-02-01 |
13G
|
ITMN /
|
|
|
2,630,588 |
|
|
|
| 2013-02-01 |
13G/A
|
OCRX / Ocera Therapeutics, Inc.
|
|
|
4,386,281 |
|
|
|
| 2013-02-01 |
13G
|
ALBO / Albireo Pharma Inc
|
|
|
1,511,500 |
|
|
|
| 2013-02-01 |
13G
|
ASMB / Assembly Biosciences, Inc.
|
|
|
1,215,840 |
|
|
|
| 2013-02-01 |
13G
|
HRTX / Heron Therapeutics, Inc.
|
|
|
30,655,851 |
|
|
|
| 2013-02-01 |
13G/A
|
DSCI / Derma Sciences, Inc.
|
|
|
1,358,857 |
|
|
|
| 2013-02-01 |
13G
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
1,498,089 |
|
|
|
| 2013-02-01 |
13G/A
|
|
|
|
9,092,486 |
|
|
|
| 2013-02-01 |
13G/A
|
PCYC / Pharmacyclics
|
|
|
11,444,360 |
|
|
|
| 2013-01-23 |
13D/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
15,621,812 |
|
|
|
| 2012-12-21 |
13D
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
15,621,812 |
|
|
|
| 2012-11-13 |
13D
|
MEIP / MEI Pharma, Inc.
|
|
|
7,840,000 |
|
|
|
